Improved cardiac function after prolonged hypothermic ischemia with the Na+/H+ exchange inhibitor HOE 694

https://doi.org/10.1016/0003-4975(96)00088-4Get rights and content

Background.

Na+/H+ exchange represents an important mechanism for pH regulation in the cardiac cell that, however, may paradoxically mediate tissue damage in the reperfused myocardium. We investigated whether inhibition of the exchanger can protect the heart against damage after prolonged hypothermic storage with the use of the selective inhibitor 3-methylsulfonyl-4-piperidinobenzoyl-guanidine methanesulfonate (HOE 694).

Methods.

After equilibration, isolated rabbit hearts were arrested with a 3 minute infusion of modified St. Thomas' cardioplegic solution and subsequently maintained in ischemic arrest at 4°C for 12 hours before reperfusion at 37°C for 60 minutes. Left ventricular function and creatine kinase release were measured at intervals throughout reperfusion. High-energy phosphate and adenine nucleotide content were determined in hearts before cardioplegia, at the end of the 12-hour storage period, and at the end of reperfusion. HOE 694 (1 μmol/L) was administered either with cardioplegia and throughout reperfusion (study 1) or selectively with either cardioplegia or reperfusion only (study 2).

Results.

In study 1, systolic function in untreated hearts recovered to less than 40% of preischemic values and was associated with a greater than 1,000% percent sustained elevation in left ventricular end-diastolic pressure. In contrast, systolic recovery in HOE 694-treated hearts was significantly accelerated and improved to approximately 80%, whereas left ventricular end-diastolic pressure increased to only 300% of baseline. Significant protection also occurred in those hearts in which HOE 694 was administered only at reperfusion while the drug was less effective if given only during cardioplegia. Creatine kinase release was not significantly affected except in study 2, where it was significantly lower after 60 minutes of reperfusion in hearts where HOE 694 was added at the time of reperfusion. Tissue metabolite content was not affected by drug treatment.

Conclusions.

This study shows a marked protective effect of the Na+/H+ exchange inhibitor HOE 694 in rabbit hearts subjected to 12 hours of hypothermic ischemia and strongly suggests that antiport inhibitors could play an effective role in myocardial preservation.

References (25)

  • RosalkiSB

    An improved procedure for serum creatine phosphokinase determination

    J Lab Clin Med

    (1967)
  • BergmeyerHV

    Methods in enzymatic analysis

    (1963)
  • Cited by (55)

    • Exploration of the optimal dose of HOE-642 for the protection of neuronal mitochondrial function after cardiac arrest in rats

      2019, Biomedicine and Pharmacotherapy
      Citation Excerpt :

      Na+/H+ exchanger isoform 1 (NHE1) is a plasma membrane protein that is present in all eukaryotic cells and plays a central role in the regulation of intracellular pH and cell volume by exchanging intracellular H+ with extracellular Na+ [5]. Inhibition of NHE has been shown to provide significant protection in a variety of models of myocardial ischemia-reperfusion, with consistent improvements in functional recovery, metabolic status, attenuation of arrhythmias, preservation of cellular ultrastructure and inhibition of apoptosis [6–11]. HOE-642, a selective NHE1 inhibitor, has demonstrated beneficial effects in patients with acute coronary syndromes [12].

    • Cardio-protective Signalling by Glyceryl Trinitrate and Cariporide in a Model of Donor Heart Preservation

      2015, Heart Lung and Circulation
      Citation Excerpt :

      Short non-lethal cycles of ischaemia and reperfusion or pharmacological agents mimicking these physiological strategies that are applied before (pre-conditioning), during (per-conditioning) or after (post-conditioning) an index period of ischaemia produce significant functional improvement during subsequent reperfusion [7]. Experimental studies indicate that such protective strategies initially employed against myocardial infarction are also effective in models of donor heart preservation and transplantation [8,9]. Previous work from our laboratory has shown that ischaemic preconditioning or the presence of pharmacological agents such as nitric oxide donors (diazenium diolates or glyceryl-trinitrate (GTN)), KATP channel openers or the sodium hydrogen exchange inhibitor cariporide at cardioplegia and during hypothermic storage significantly improved post-storage cardiac function in an isolated working rat heart model of donor heart preservation [10–12].

    • Optimal Dose and Mode of Delivery of Na<sup>+</sup>/H<sup>+</sup> Exchange-1 Inhibitor Are Critical for Reducing Postsurgical Ischemia- Reperfusion Injury

      2003, Annals of Thoracic Surgery
      Citation Excerpt :

      In the control group, there was a significantly greater relaxation response in the left circumflex coronary artery compared with the ischemic-reperfused LAD (p = 0.03). Inhibition of NHE1 during the period of cardioplegic arrest has been shown to improve postischemic recovery of LV function in isolated Langendorff preparations of the rat and rabbit [27–29]. In dogs, NHE 1 inhibitor in crystalloid cardioplegia decreases myocardial edema and preserves preload-recruitable stroke work after CPB in normal hearts [30, 31].

    View all citing articles on Scopus

    This study was supported by the Heart and Stroke Foundation of Ontario (HSFO grant A2400) and the Medical Research Council of Canada (grant MT-10284).

    View full text